Comparing subjective quality of recovery between remimazolam- and propofol-based total intravenous anesthesia for surgical procedures: a meta-analysis.
General anesthesia
Propofol
QoR
Quality of recovery
Remimazolam
Journal
Systematic reviews
ISSN: 2046-4053
Titre abrégé: Syst Rev
Pays: England
ID NLM: 101580575
Informations de publication
Date de publication:
17 Sep 2024
17 Sep 2024
Historique:
received:
23
06
2024
accepted:
08
09
2024
medline:
18
9
2024
pubmed:
18
9
2024
entrez:
17
9
2024
Statut:
epublish
Résumé
Remimazolam is a novel ultra-short-acting benzodiazepine that has been recently introduced as an alternative to propofol for general anesthesia. While both agents have been compared in terms of safety and efficacy, their relative effects on postoperative quality of recovery (QoR) remain unclear. Therefore, this meta-analysis aimed to compare the effects of remimazolam and propofol on subjective QoR in surgical patients who underwent general anesthesia. Medline, Embase, Google Scholar, and the Cochrane Central Register of Controlled Trials were searched from inception to May 28, 2024 to identify randomized controlled trials comparing remimazolam and propofol in terms of postoperative QoR. The Cochrane risk-of-bias tool (RoB 2) was used to assess study quality. QoR score on postoperative day (POD) 1 (primary outcome), QoR scores on PODs 2-3, QoR dimensions, time to loss of consciousness, other recovery characteristics, and rescue analgesia requirement were evaluated using random-effects meta-analyses. This meta-analysis included 13 studies published between 2022 and 2024 involving 1,418 patients. QoR was evaluated using either the QoR-15 (10 studies) or QoR-40 (3 studies) questionnaire. The pooled results indicated no significant difference in the QoR scores on POD 1 (standardized mean difference: 0.02, 95% confidence interval [CI]: - 0.20, 0.23, P = 0.88, I Remimazolam is a potential alternative to propofol for general anesthesia as it offers similar QoR to the latter and has advantages in terms of consciousness recovery and immediate postoperative analgesia requirement.
Sections du résumé
BACKGROUND
BACKGROUND
Remimazolam is a novel ultra-short-acting benzodiazepine that has been recently introduced as an alternative to propofol for general anesthesia. While both agents have been compared in terms of safety and efficacy, their relative effects on postoperative quality of recovery (QoR) remain unclear. Therefore, this meta-analysis aimed to compare the effects of remimazolam and propofol on subjective QoR in surgical patients who underwent general anesthesia.
METHODS
METHODS
Medline, Embase, Google Scholar, and the Cochrane Central Register of Controlled Trials were searched from inception to May 28, 2024 to identify randomized controlled trials comparing remimazolam and propofol in terms of postoperative QoR. The Cochrane risk-of-bias tool (RoB 2) was used to assess study quality. QoR score on postoperative day (POD) 1 (primary outcome), QoR scores on PODs 2-3, QoR dimensions, time to loss of consciousness, other recovery characteristics, and rescue analgesia requirement were evaluated using random-effects meta-analyses.
RESULTS
RESULTS
This meta-analysis included 13 studies published between 2022 and 2024 involving 1,418 patients. QoR was evaluated using either the QoR-15 (10 studies) or QoR-40 (3 studies) questionnaire. The pooled results indicated no significant difference in the QoR scores on POD 1 (standardized mean difference: 0.02, 95% confidence interval [CI]: - 0.20, 0.23, P = 0.88, I
CONCLUSION
CONCLUSIONS
Remimazolam is a potential alternative to propofol for general anesthesia as it offers similar QoR to the latter and has advantages in terms of consciousness recovery and immediate postoperative analgesia requirement.
Identifiants
pubmed: 39289773
doi: 10.1186/s13643-024-02660-8
pii: 10.1186/s13643-024-02660-8
doi:
Substances chimiques
remimazolam
7V4A8U16MB
Propofol
YI7VU623SF
Benzodiazepines
12794-10-4
Anesthetics, Intravenous
0
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
235Informations de copyright
© 2024. The Author(s).
Références
Wessels E, Perrie H, Scribante J, Jooma Z. Quality of recovery in the perioperative setting: A narrative review. J Clin Anesth. 2022;78: 110685.
pubmed: 35190342
doi: 10.1016/j.jclinane.2022.110685
Myles PS. More than just morbidity and mortality - quality of recovery and long-term functional recovery after surgery. Anaesthesia. 2020;75(Suppl 1):e143–50.
pubmed: 31903564
Myles P, Weitkamp B, Jones K, Melick J, Hensen S. Validity and reliability of a postoperative quality of recovery score: the QoR-40. Br J Anaesth. 2000;84:11–5.
pubmed: 10740540
doi: 10.1093/oxfordjournals.bja.a013366
Gornall B, Myles PS, Smith C, Burke J, Leslie K, Pereira M, et al. Measurement of quality of recovery using the QoR-40: a quantitative systematic review. Br J Anaesth. 2013;111:161–9.
pubmed: 23471753
doi: 10.1093/bja/aet014
Myles PS, Shulman MA, Reilly J, Kasza J, Romero L. Measurement of quality of recovery after surgery using the 15-item quality of recovery scale: a systematic review and meta-analysis. Br J Anaesth. 2022;128:1029–39.
pubmed: 35430086
doi: 10.1016/j.bja.2022.03.009
Campfort M, Cayla C, Lasocki S, Rineau E, Léger M. Early quality of recovery according to QoR-15 score is associated with one-month postoperative complications after elective surgery. J Clin Anesth. 2022;78: 110638.
pubmed: 35033845
doi: 10.1016/j.jclinane.2021.110638
Kinugasa Y, Ida M, Nakatani S, Uyama K, Kawaguchi M. Quality of recovery in hospital and disability-free survival at three months after major abdominal surgery. Korean J Anesthesiol. 2023;76:567–74.
pubmed: 37165623
pmcid: 10718636
doi: 10.4097/kja.23082
Niu Z, Gao X, Shi Z, Liu T, Wang M, Guo L, et al. Effect of total intravenous anesthesia or inhalation anesthesia on postoperative quality of recovery in patients undergoing total laparoscopic hysterectomy: A randomized controlled trial. J Clin Anesth. 2021;73: 110374.
pubmed: 34090183
doi: 10.1016/j.jclinane.2021.110374
Han S, Park J, Hong SH, Lim S, Park YH, Chae MS. Comparison of the impact of propofol versus sevoflurane on early postoperative recovery in living donors after laparoscopic donor nephrectomy: a prospective randomized controlled study. BMC Anesthesiol. 2020;20:273.
pubmed: 33115408
pmcid: 7592560
doi: 10.1186/s12871-020-01190-9
Xu M, Zhang G, Tang Y, Wang R, Yang J. Impact of Regional Anesthesia on Subjective Quality of Recovery in Patients Undergoing Thoracic Surgery: A Systematic Review and Meta-Analysis. J Cardiothorac Vasc Anesth. 2023;37:1744–50.
pubmed: 37301699
doi: 10.1053/j.jvca.2023.05.003
Miao M, Xu Y, Li B, Chang E, Zhang L, Zhang J. Intravenous administration of dexmedetomidine and quality of recovery after elective surgery in adult patients: A meta-analysis of randomized controlled trials. J Clin Anesth. 2020;65: 109849.
pubmed: 32403055
doi: 10.1016/j.jclinane.2020.109849
Hung KC, Kao CL, Ho CN, Hsing CH, Chang YJ, Wang LK, et al. The impact of perioperative ketamine or esketamine on the subjective quality of recovery after surgery: a meta-analysis of randomised controlled trials. Br J Anaesth. 2024;132:1293–303.
pubmed: 38614917
doi: 10.1016/j.bja.2024.03.012
Hung KC, Ko CC, Hsu CW, Pang YL, Chen JY, Sun CK. Association of peripheral nerve blocks with patient-reported quality of recovery in female patients receiving breast cancer surgery: a systematic review and meta-analysis of randomized controlled studies. Can J Anaesth. 2022;69:1288–99.
pubmed: 35882724
doi: 10.1007/s12630-022-02295-0
Hung KC, Chu CC, Hsing CH, Chang YP, Li YY, Liu WC, et al. Association between perioperative intravenous lidocaine and subjective quality of recovery: A meta-analysis of randomized controlled trials. J Clin Anesth. 2021;75: 110521.
pubmed: 34547603
doi: 10.1016/j.jclinane.2021.110521
Peng K, Liu H-Y, Wu S-R, Liu H, Zhang Z-C, Ji F-H. Does Propofol Anesthesia Lead to Less Postoperative Pain Compared With Inhalational Anesthesia?: A Systematic Review and Meta-analysis. Anesth Analg. 2016;123:846–58.
pubmed: 27636574
doi: 10.1213/ANE.0000000000001504
Schraag S, Pradelli L, Alsaleh AJO, Bellone M, Ghetti G, Chung TL, et al. Propofol vs. inhalational agents to maintain general anaesthesia in ambulatory and in-patient surgery: a systematic review and meta-analysis. BMC Anesthesiol. 2018;18:162.
pubmed: 30409186
pmcid: 6225663
doi: 10.1186/s12871-018-0632-3
Kampman JM, Hermanides J, Hollmann MW, Gilhuis CN, Bloem WA, Schraag S, et al. Mortality and morbidity after total intravenous anaesthesia versus inhalational anaesthesia: a systematic review and meta-analysis. EClinicalMedicine. 2024;72: 102636.
pubmed: 38774674
pmcid: 11106536
doi: 10.1016/j.eclinm.2024.102636
Kim KM. Remimazolam: pharmacological characteristics and clinical applications in anesthesiology. Anesth Pain Med (Seoul). 2022;17:1–11.
pubmed: 35139608
doi: 10.17085/apm.21115
Wesolowski AM, Zaccagnino MP, Malapero RJ, Kaye AD, Urman RD. Remimazolam: Pharmacologic Considerations and Clinical Role in Anesthesiology. Pharmacotherapy. 2016;36:1021–7.
pubmed: 27496519
doi: 10.1002/phar.1806
Kilpatrick GJ. Remimazolam: Non-Clinical and Clinical Profile of a New Sedative/Anesthetic Agent. Front Pharmacol. 2021;12: 690875.
pubmed: 34354587
pmcid: 8329483
doi: 10.3389/fphar.2021.690875
Huang L, Liu H, Zou X, Ding J, Tao S. Adverse Drug Events Observed with the Newly Approved Remimazolam in Comparison to Propofol for General Anesthesia in Patients Undergoing Surgery: A Meta-analysis. Adv Ther. 2024;41:1896–910.
pubmed: 38480661
doi: 10.1007/s12325-024-02820-1
Barbosa EC, Espírito Santo PA, Baraldo S, Meine GC. Remimazolam versus propofol for sedation in gastrointestinal endoscopic procedures: a systematic review and meta-analysis. Br J Anaesth. 2024;132:1219–29.
pubmed: 38443286
doi: 10.1016/j.bja.2024.02.005
An X, Shen T, Yin X, Xu J, Zhang Y, Wang T. The safety of remimazolam versus propofol in gastroscopic sedation: a meta-analysis. BMC Anesthesiol. 2024;24:40.
pubmed: 38287259
pmcid: 10823673
doi: 10.1186/s12871-024-02422-y
Peng X, Liu C, Zhu Y, Peng L, Zhang X, Wei W, et al. Hemodynamic Influences of Remimazolam Versus Propofol During the Induction Period of General Anesthesia: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Pain Physician. 2023;26:E761–73.
pubmed: 37976477
Zhao MJ, Hu HF, Li XL, Li XM, Wang DC, Kuang MJ. The safety and efficacy between remimazolam and propofol in intravenous anesthesia of endoscopy operation: a systematic review and meta-analysis. Int J Surg. 2023;109:3566–77.
pubmed: 37534687
pmcid: 10651250
doi: 10.1097/JS9.0000000000000638
Wu X, Wang C, Gao H, Bai X, Zhang Z, Chen R, et al. Comparison of remimazolam and propofol about safety outcome indicators during general anesthesia in surgical patients: a systematic review and meta-analysis. Minerva Anestesiol. 2023;89:553–64.
pubmed: 36852570
doi: 10.23736/S0375-9393.23.17034-9
Qin F, Lian Z, Huang Y, Tian D. Remimazolam as a Potential Alternative to Propofol for General Anesthesia: A Meta-Analysis of Randomized Controlled Trials. Journal of Anesthesia and Translational Medicine. 2023;2:1–10.
doi: 10.58888/2957-3912-2023-03-01
Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.
pubmed: 25524443
pmcid: 4383202
doi: 10.1186/1471-2288-14-135
Chen H-T, Hung K-C, Huang Y-T, Wu J-Y, Hsing C-H, Lin C-M, et al. Efficacy of electroacupuncture in improving postoperative ileus in patients receiving colorectal surgery: a systematic review and meta-analysis. Int J Surg. 2024;110:1113–25.
pubmed: 37916930
doi: 10.1097/JS9.0000000000000848
Myles PS, Myles DB. An Updated Minimal Clinically Important Difference for the QoR-15 Scale. Anesthesiology. 2021;135:934–5.
pubmed: 34543410
doi: 10.1097/ALN.0000000000003977
Wu Q, Xu F, Wang J, Jiang M. Comparison of Remimazolam-Flumazenil versus Propofol for Recovery from General Anesthesia: A Systematic Review and Meta-Analysis. J Clin Med. 2023;12:7316.
pubmed: 38068368
pmcid: 10707179
doi: 10.3390/jcm12237316
Choi JY, Lee HS, Kim JY, Han DW, Yang JY, Kim MJ, et al. Comparison of remimazolam-based and propofol-based total intravenous anesthesia on postoperative quality of recovery: A randomized non-inferiority trial. J Clin Anesth. 2022;82: 110955.
pubmed: 36029704
doi: 10.1016/j.jclinane.2022.110955
Huang Y, Yan T, Lu G, Luo H, Lai Z, Zhang L. Efficacy and safety of remimazolam compared with propofol in hypertensive patients undergoing breast cancer surgery: a single-center, randomized, controlled study. BMC Anesthesiol. 2023;23:409.
pubmed: 38087245
pmcid: 10714447
doi: 10.1186/s12871-023-02364-x
Jiao Z, Wang P, Meng R, Wang K, Xiao R, Yuan M. Effects of remimazolam combined with mivacurium on recovery quality of patients after vocal cord polypectomy. Chin J Clin Res. 2024;37(4):534–9.
Kim EJ, Kim CH, Yoon JY, Byeon GJ, Kim HY, Choi EJ. Comparison of postoperative nausea and vomiting between Remimazolam and Propofol in Patients undergoing oral and maxillofacial surgery: a prospective Randomized Controlled Trial. BMC Anesthesiol. 2023;23:132.
pubmed: 37085760
pmcid: 10122311
doi: 10.1186/s12871-023-02091-3
Kotani T, Ida M, Naito Y, Kawaguchi M. Comparison of remimazolam-based and propofol-based total intravenous anesthesia on hemodynamics during anesthesia induction in patients undergoing transcatheter aortic valve replacement: a randomized controlled trial. J Anesthesia. 2024:1–9.
Lee H-J, Lee HB, Kim YJ, Cho H-Y, Kim WH, Seo J-H. Comparison of the recovery profile of remimazolam with flumazenil and propofol anesthesia for open thyroidectomy. BMC Anesthesiol. 2023;23:147.
pubmed: 37131126
pmcid: 10152604
doi: 10.1186/s12871-023-02104-1
Lee J, Han DW, Song Y, Lee J, Jeon S, Kim MH. Quality of Postoperative Recovery in Total Intravenous Anesthesia between Remimazolam and Propofol for Intraoperative Neurophysiological Monitoring: A Prospective Double-Blind Randomized Controlled Trial. J Pers Med. 2024;14(4):382.
pubmed: 38673009
pmcid: 11051443
doi: 10.3390/jpm14040382
Luo L, Jiang J, Zhang M, Guo Z, Zhang X, Wang F, et al. Comparative Study About Different Doses of Remimazolam in Short Laparoscopic Surgery: A Randomized Controlled Double-Blind Trial. Ther Clin Risk Manag. 2023:829–37.
Mao Y, Guo J, Yuan J, Zhao E, Yang J. Quality of Recovery After General Anesthesia with Remimazolam in Patients’ Undergoing Urologic Surgery: A Randomized Controlled Trial Comparing Remimazolam with Propofol. Drug Des Devel Ther. 2022;16:1199–209.
pubmed: 35509490
pmcid: 9058002
doi: 10.2147/DDDT.S359496
Tang L, Sun Y, Hao X, Sun X, Xie C, Wang T, et al. Effect of general anaesthesia with remimazolam versus propofol on postoperative quality of recovery in patients undergoing ambulatory arthroscopic meniscus repair: a randomised clinical trial. BJA Open. 2023;8: 100237.
pubmed: 37942055
pmcid: 10630608
doi: 10.1016/j.bjao.2023.100237
Zhao S, Lu X, Lyu S, Shan Y, Miao C. Effects of remimazolam versus propofol on postoperative recovery quality in elderly patients undergoing thoracoscopic laparoscopic radical esophagectomy [Chinese]. Natl Med J Chin. 2023;103(17):1303–9.
Chen H, Wang H, Wang Y, Su S, Wang G. Remimazolam versus propofol on quality of recovery after general anesthesia in elders undergoing ocular fundus daytime surgery. J Pract Med. 2024;40:1052–7.
Lee J, Kim DH, Ju JW, Nam K, Cho YJ, Jeon Y, et al. Comparison of recovery profiles between total intravenous anaesthesia with propofol or remimazolam reversed with flumazenil in patients undergoing breast surgery: A randomised controlled trial. Eur J Anaesthesiol. 2024;41:199–207.
pubmed: 38205822
doi: 10.1097/EJA.0000000000001951
Li FZ, Zhao C, Tang YX, Liu JT. Safety and efficacy comparison of remimazolam and propofol for intravenous anesthesia during gastroenteroscopic surgery of older patients: A meta-analysis. World J Clin Cases. 2024;12:1272–83.
pubmed: 38524507
pmcid: 10955534
doi: 10.12998/wjcc.v12.i7.1272
Terres MT, Assis ML, CB DAS, Amaral S. Remimazolam versus propofol for endoscopy sedation in elderly patients: a systematic review, meta-analysis and trial sequential analysis. Minerva Anestesiol. 2024. Online ahead of print.
Collins J, O’Sullivan EP. Rapid sequence induction and intubation. BJA Educ. 2022;22:484–90.
pubmed: 36406036
pmcid: 9669739
doi: 10.1016/j.bjae.2022.09.001
de Carvalho CC, da Silva DM, de Athayde Regueira SLP, de Souza ABS, Rego CO, Ramos IB, et al. Comparison between rocuronium and succinylcholine for rapid sequence induction: A systematic review and network meta-analysis of randomized clinical trials. J Clin Anesth. 2021;72: 110265.
pubmed: 33819827
doi: 10.1016/j.jclinane.2021.110265
Sokal SM, Craft DL, Chang Y, Sandberg WS, Berger DL. Maximizing operating room and recovery room capacity in an era of constrained resources. Arch Surg. 2006;141:389–95.
pubmed: 16618898
doi: 10.1001/archsurg.141.4.389
Fields A, Huang J, Schroeder D, Sprung J, Weingarten T. Agitation in adults in the post-anaesthesia care unit after general anaesthesia. Br J Anaesth. 2018;121:1052–8.
pubmed: 30336849
doi: 10.1016/j.bja.2018.07.017
Royse CF, Chung F, Newman S, Stygall J, Wilkinson DJ. Predictors of patient satisfaction with anaesthesia and surgery care: a cohort study using the Postoperative Quality of Recovery Scale. Eur J Anaesthesiol. 2013;30:106–10.
pubmed: 22907610
doi: 10.1097/EJA.0b013e328357e584
Wu L, Huang X, Sun L. The efficacy of N-methyl-D-aspartate receptor antagonists on improving the postoperative pain intensity and satisfaction after remifentanil-based anesthesia in adults: a meta-analysis. J Clin Anesth. 2015;27:311–24.
pubmed: 25824051
doi: 10.1016/j.jclinane.2015.03.020
Fletcher D, Martinez V. Opioid-induced hyperalgesia in patients after surgery: a systematic review and a meta-analysis. Br J Anaesth. 2014;112:991–1004.
pubmed: 24829420
doi: 10.1093/bja/aeu137
Ren YL, Yuan JJ, Xing F, Zhu LN, Zhang W. Effects of Different Doses of Esketamine on Pain Sensitivity of Patients Undergoing Thyroidectomy: A Randomized Controlled Trial. Pain Ther. 2023;12:739–50.
pubmed: 36933139
pmcid: 10199971
doi: 10.1007/s40122-023-00488-z
Wu Z, Yu J, Lin Q, Li H, Zhang T, Tan H, et al. Effects of an Intraoperative Intravenous Bolus Dose of Dexmedetomidine on Remifentanil-Induced Postinfusion Hyperalgesia in Patients Undergoing Thyroidectomy: A Double-Blind Randomized Controlled Trial. Anesth Analg. 2021;132:320–8.
pubmed: 32639389
doi: 10.1213/ANE.0000000000005003
Lee C, Lim J, Hong H, Yu H, Lee H. Effect of Remimazolam on Pain Perception and Opioid-Induced Hyperalgesia in Patients Undergoing Laparoscopic Urologic Surgery-A Prospective, Randomized, Controlled Study. Medicina (Kaunas). 2024;60(1):123.
pubmed: 38256384
pmcid: 10818426
doi: 10.3390/medicina60010123
Hoshino R, Ohashi N, Uta D, Ohashi M, Deguchi H, Baba H. Actions of remimazolam on inhibitory transmission of rat spinal dorsal horn neurons. J Pharmacol Sci. 2024;155:63–73.
pubmed: 38677787
doi: 10.1016/j.jphs.2024.04.002
Xie H, Lu F, Liu W, Wang E, Wang L, Zhong M. Remimazolam alleviates neuropathic pain via regulating bradykinin receptor B1 and autophagy. J Pharm Pharmacol. 2021;73:1643–51.
pubmed: 34061162
doi: 10.1093/jpp/rgab080